title: [Evaluation of American Joint Commission on Cancer(8thedition) and Japanese Pancreas Society(7thedition)changes for T and N staging in patients with pancreatic adenocarcinoma].
abstract: Accurate staging for cancer is the basis for clinical practice, individualized treatment strategy, and prognosis determination.Recently, the T and N staging systems for pancreatic adenocarcinoma were updated by both American Joint Commission on Cancer(AJCC)8thedition and Japanese Pancreas Society 7thedition, in which more objective parameters were applied.When a large number of patients within the test set were staged, AJCC 8thedition has showed more reproducible and helped to predict the patient prognosis more accurately.
authors.affiliation: Department of Surgery, Beijing University First Hospital, Beijing 100034, China.
authors.forename: Y M
authors.initials: YM
authors.lastname: Yang
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis*; D006801:Humans; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000175:diagnosis*; D011379:Prognosis